By Elric Langton | 11 May 2022
I have a financial interest in Poolbeg Pharma
Poolbeg Pharma Plc (AIM: POLB, OTCQB: POLBF), a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model, has announced that it will be participating in the upcoming European Melioidosis Congress (EMC) 2022, due to take place from 16 Mayβ¦